uSTEM is proprietary of an extremely efficient microfluidic cell reprogramming method, covered by five patents and a prestigious international publication (Nature Methods 13, 446–452; 2016)
4 years of dedicated and passionate R&D have allowed us to develop a reprogramming method based on microtechnologies.
The results are striking:
- 50-fold efficiency enhancement;
- 200-fold reduction in reagents volume;
- 40-fold reduction in cell number.
Our method enables us to reprogram, expand and characterize the obtained iPSCs in less than 2 months, using a very limited quantity of reagents and with a successful rate above 30%, with peaks of 150% – depending, of course, not only on the method but also on the quality of donor cells.